FDA.reportPublic FDA data

belladonna alkaloids 0.2 MG / ergotamine tartrate 0.6 MG / phenobarbital 40 MG Oral Tablet

RxCUI
1294394
RxNorm name
belladonna alkaloids 0.2 MG / ergotamine tartrate 0.6 MG / phenobarbital 40 MG Oral Tablet
Term type
SCD
Status
Active
Updated
2026-10-30 15:30:36

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062012
Active start
062012
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
belladonna alkaloids0.2 MG / 1 EACHbelladonna alkaloidsbelladonna alkaloids
ergotamine tartrate0.6 MG / 1 EACHergotamineergotamine tartrate
phenobarbital40 MG / 1 EACHphenobarbitalphenobarbital

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
belladonna alkaloids1359
ergotamine4025
phenobarbital8134

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRbelladonna alkaloids 0.2 MG / ergotamine tartrate 0.6 MG / PHENobarbital 40 MG Oral Tablet1NAMES
RxNorm Namebelladonna alkaloids 0.2 MG / ergotamine tartrate 0.6 MG / phenobarbital 40 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
RxCUI12943941CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00179160570rxnav_historical
00179160571rxnav_historical
00179160572rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN03AABarbiturates and derivativesATC1-4phenobarbital
ATCN02CAErgot alkaloidsATC1-4ergotamine
FDASPLD004879ErgotaminesCHEMhas_chemical_structureergotamine
FDASPLN0000175766Ergotamine DerivativeEPChas_epcergotamine
MEDRTD001393AzolesCHEMci_chemclassergotamine
MEDRTD001393AzolesCHEMci_chemclassergotamine tartrate
MEDRTD001533Belladonna AlkaloidsCHEMhas_ingredientbelladonna alkaloids
MEDRTD002219CarbamatesCHEMci_chemclassergotamine tartrate
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine tartrate
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine
MEDRTD005663FuransCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine tartrate
MEDRTD018942MacrolidesCHEMci_chemclassergotamine
MEDRTD019888NelfinavirCHEMci_chemclassergotamine tartrate
MEDRTD010634PhenobarbitalCHEMhas_ingredientphenobarbital
MEDRTD019438RitonavirCHEMci_chemclassergotamine tartrate
MEDRTD013449SulfonamidesCHEMci_chemclassergotamine tartrate
MEDRTD000033Abortion, ThreatenedDISEASEci_withergotamine tartrate
MEDRTD000402Airway ObstructionDISEASEci_withphenobarbital
MEDRTD000437AlcoholismDISEASEci_withbelladonna alkaloids
MEDRTD000788Angina Pectoris, VariantDISEASEmay_diagnoseergotamine tartrate
MEDRTD001249AsthmaDISEASEci_withbelladonna alkaloids
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine tartrate
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine tartrate
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withphenobarbital
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine tartrate
MEDRTD004828Epilepsies, PartialDISEASEmay_treatphenobarbital
MEDRTD020936Epilepsy, Benign NeonatalDISEASEmay_treatphenobarbital
MEDRTD004830Epilepsy, Tonic-ClonicDISEASEmay_treatphenobarbital
MEDRTD005767Gastrointestinal DiseasesDISEASEmay_treatbelladonna alkaloids
MEDRTD005901GlaucomaDISEASEci_withbelladonna alkaloids
MEDRTD006261HeadacheDISEASEmay_treatbelladonna alkaloids
MEDRTD006932HyperbilirubinemiaDISEASEmay_treatphenobarbital
MEDRTD006973HypertensionDISEASEci_withergotamine
MEDRTD006973HypertensionDISEASEci_withergotamine tartrate
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine
MEDRTD007674Kidney DiseasesDISEASEci_withbelladonna alkaloids
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine tartrate
MEDRTD008107Liver DiseasesDISEASEci_withergotamine
MEDRTD008107Liver DiseasesDISEASEci_withergotamine tartrate
MEDRTD008107Liver DiseasesDISEASEci_withbelladonna alkaloids
MEDRTD017093Liver FailureDISEASEci_withphenobarbital
MEDRTD008593MenopauseDISEASEmay_treatbelladonna alkaloids
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine tartrate
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine tartrate
MEDRTD011164PorphyriasDISEASEci_withphenobarbital
MEDRTD006473Postpartum HemorrhageDISEASEmay_preventergotamine tartrate
MEDRTD006473Postpartum HemorrhageDISEASEmay_treatergotamine tartrate
MEDRTD011247PregnancyDISEASEci_withergotamine
MEDRTD011247PregnancyDISEASEci_withergotamine tartrate
MEDRTD011247PregnancyDISEASEci_withphenobarbital
MEDRTD012640SeizuresDISEASEci_withbelladonna alkaloids
MEDRTD003294Seizures, FebrileDISEASEmay_treatphenobarbital
MEDRTD018805SepsisDISEASEci_withergotamine
MEDRTD018805SepsisDISEASEci_withergotamine tartrate
MEDRTD013035SpasmDISEASEmay_treatbelladonna alkaloids
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine tartrate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moabelladonna alkaloids
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine tartrate
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine tartrate
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine tartrate
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moaphenobarbital
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine tartrate
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine
MEDRTN0000008376Cutaneous Arterial VasoconstrictionPEhas_peergotamine tartrate
MEDRTN0000008701Decreased Medullary Respiratory DrivePEci_pebelladonna alkaloids
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_pebelladonna alkaloids
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pebelladonna alkaloids
MEDRTN0000009027Electrical Activity AlterationPEhas_pephenobarbital
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine tartrate
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine
MEDRTN0000009808Positive ChronotropyPEhas_pebelladonna alkaloids
MEDRTN0000009820Pupillary DilationPEhas_pebelladonna alkaloids
MEDRTN0000009842Salivation InhibitionPEhas_pebelladonna alkaloids

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
CODESSNOMEDCT377225006
CODESVUID4006418
NAMESPrescribable Synonymbelladonna alkaloids 0.2 MG / ergotamine tartrate 0.6 MG / PHENobarbital 40 MG Oral Tablet
NAMESTallman Synonymbelladonna alkaloids 0.2 MG / ergotamine tartrate 0.6 MG / PHENobarbital 40 MG Oral Tablet
SOURCESSourceUS Edition of SNOMED_CT